Midatech Pharma (MTPH)

Company name:Midatech Pharma Plc
EPIC:MTPHTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BRTL9B63
Market Segment:ASQ1Share Type:DE
WWW Address:http://midatechgroup.com/investorsDescription:ORD 0.005P
 Price Price Change [%] Bid Offer Open High Low Volume
 2.40 images.advfn.com/imagesnew/2/gb/down -0.35 [-12.73] 2.30 2.50 2.60 2.65 2.35 4,712,421
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 9.83 409.40 -0.25 25.00 - 0.10 - 13.75 - 2.35

Midatech Pharma Key Figures

(at previous day's close)
Market Cap.9.83m
Shares In Issue409.40m
Prev. Close2.75
PE Ratio0.10 
Dividend Yield-%
EPS - basic25.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-3.29p
Return On Equity (ROE)-88.81%
Operating Margin-8,322.15%
PEG Factor0.00 
EPS Growth Rate180.65%
Dividends PS Growth Rate-%
Net Debt1.18m
Gross Gearing17.22%
Quick Assets6.09m
Net Working Capital3.62m
Intangibles / Fixed Assets86.19%
Turnover PS0.04p
Pre-Tax Profit PS-3.03p
Retained Profit PS-3.67p
Cash PS0.57p
Net Cash PS-0.03p
Net Tangible Asset Value PS *1.11p
Net Asset Value PS4.13p
Spread0.20 (8.00%) 

Midatech Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week3.752.35
4 weeks4.702.35
12 weeks6.502.35
1 year13.752.35

Share Price Chart (5 years)

Midatech Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week2.90-0.50-17.242.351.982.75
4 weeks3.65-1.25-34.252.350.612.83
12 weeks5.50-3.10-56.362.350.484.29
26 weeks5.75-3.35-58.262.350.465.52
1 year9.25-6.85-74.052.351.106.75
3 years118.50-116.10-97.972.350.4411.72
5 years280.00-277.60-99.142.350.2719.34

Midatech Pharma Key Management Ratios

Midatech Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio0.10 
Tobin's Q Ratio 0.28 
Tobin's Q Ratio (excl. intangibles)0.66 
Dividend Yield-%
Market-to-Book Ratio0.58 
Price-to-Pre-Tax Profit PS-0.79 
Price-to-Retained Profit PS-0.65 
Price-to-Cash Flow PS-0.73 
Price-to-Sales PS65.94 
Price-to-Net Tangible Asset Value PS2.16 
Price-to-Cash PS4.19 
Net Working Capital PS0.88 
Price Pct to Working Capital PS2.72%
Earnings Yield1,041.67%
Average PE0.24 
Years in average1 
PE to PE average40.00%

Midatech Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio5.84%
Debt-to-Equity Ratio0.06 
Debt-to-Equity Ratio (excl. Intgbl)0.23 
Debt-to-Equity Market Value0.11 
Net Gearing5.76%
Net Gearing (excl. Intangibles)14.58%
Gross Gearing17.22%
Gross Gearing (excl. Intangibles)43.62%
Gearing Under 1 Year12.09%
Gearing Under 1 Year (excl. Intgbl)30.62%
(Liquidity Ratios)
Net Working Capital to Total Assets17.69%
Current Ratio2.46 
Quick Ratio (Acid Test)2.46 
Liquidity Ratio0.95 
Cash & Equiv/Current Assets38.49%
(Solvency Ratios)
Enterprise Value8.53m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.36 
Total Debt/Sales23.62 
Total Debt/Pre-Tax Profit-0.28 
Total Debt3.52m
Total Debt/Net Current Assets0.97%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)

Midatech Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-68.99%
Return On Assets (ROA)-43.15%
Net Profit Margin-10,087.25%
Assets Turnover0.00 
Return On Equity (ROE)-88.81%
Return On Investment (ROI)-51.09%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-58.26%
Net Income Of Revenues-10,087.25%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.01 
Fixed Assets Turnover0.01 
Current Assets Turnover0.01 
Net Working Capital Turnover 
Inventory Turnover0.32 
(Other Operating Ratios)
Total Assets-to-Sales233.79 
Debt Collection Period10,591.12Days

Midatech Pharma Dividends

Sorry No Data Available

Midatech Pharma Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
pre tax profit-11.23-816.87%-29.32-423.54%-17.33-256.42%-12.40-m
attributable profit-10.10-734.47%-20.16-291.23%-16.06-237.70%-15.03-m
retained profit-10.10-734.47%-20.16-291.23%-16.06-237.70%-15.03-m
eps - basic (p)-36.00 -56.00 -31.00 25.00 
eps - diluted (p)-36.00 -56.00 -31.00 25.00 
dividends per share- - - - 

Midatech Pharma Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
fixed assets fixed assets1.983.10%2.774.88%2.535.14%1.989.70%m
intangibles intangibles41.3464.55%31.1754.99%27.6556.17%12.3760.53%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.460.72%0.821.44%0.941.91%--%m
debtors debtors4.086.38%4.337.63%4.909.96%3.7418.31%m
cash & securities cash & securities16.1825.26%17.6131.06%13.2026.82%2.3411.46%m
creditors - short creditors - short9.1014.21%9.3516.48%8.3616.99%2.4712.09%m
creditors - long creditors - long8.0612.58%1.622.86%6.1912.57%1.055.13%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves46.8973.21%45.7280.66%34.6870.45%16.9282.78%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Midatech Pharma Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-12.42-13.09-12.95-13.45m
Pre-Financing CF-13.95-14.29-14.42-4.41m
Retained CF-14.170.97-4.15-10.88m

Midatech Pharma Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Midatech P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191207 01:24:21